Curis
CRIS
#10379
Rank
C$24.29 M
Marketcap
C$0.62
Share price
-4.89%
Change (1 day)
-81.39%
Change (1 year)

Earnings for Curis (CRIS)

Earnings in 2025 (TTM): -C$45.86 Million

According to Curis's latest financial reports the company's current earnings are C$11.65 Million. In 2024 the company made an earning of -C$59.64 Million, an increase over its 2023 earnings that were of -C$63.29 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Curis from 2001 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -C$45.86 Million-23.11%
2024 -C$59.64 Million-5.77%
2023 -C$63.29 Million-13.1%
2022 -C$72.83 Million27.52%
2021 -C$57.12 Million65.09%
2020 -C$34.6 Million-9.1%
2019 -C$38.06 Million-4.73%
2018 -C$39.95 Million-41.95%
2017 -C$68.81 Million-14.37%
2016 -C$80.36 Million3.55%
2015 -C$77.6 Million271.52%
2014 -C$20.89 Million76.64%
2013 -C$11.83 Million
2011 -C$10.05 Million27.76%
2010 -C$7.87 Million-43.87%
2009 -C$14.01 Million-23.44%
2008 -C$18.3 Million56.66%
2007 -C$11.68 Million-16.71%
2006 -C$14.02 Million-36.92%
2005 -C$22.23 Million156.25%
2004 -C$8.68 Million-37.24%
2003 -C$13.82 Million-93.34%
2002 -C$0.21 Billion86.79%
2001 -C$0.12 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
C$14.76 B-32,629.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$13.37 B-29,576.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-C$86.28 Million 90.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
C$1.39 B-3,181.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-C$0.41 Billion 782.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-C$34.53 Million-23.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
C$0.23 B-607.71%๐Ÿ‡บ๐Ÿ‡ธ USA